Skip to main content

Day: June 2, 2021

PAVmed Launches Digital Health Company Veris Health Inc.

New subsidiary Veris acquires privately held oncology digital health company Oncodisc Inc. Technologies include first intelligent implantable vascular access port with biologic sensors and wireless communication combined with remote oncology digital healthcare platform NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced the launch of a new subsidiary, digital health company Veris Health Inc. (“Veris”), which acquired Oncodisc Inc. (“Oncodisc”), a digital health company with groundbreaking tools to improve personalized cancer care through remote patient monitoring. Oncodisc was founded by experienced physician entrepreneurs, James Mitchell, M.D., who joins Veris as its full-time...

Continue reading

VivoPower International PLC Announces Proposed $58m Nordic Distribution Deal for Tembo Electric Light Vehicles

Upon completion, Arctic Trucks Limited would commit to purchase 800 electric light vehicle conversion kits from VivoPower subsidiary Tembo e-LV B.V over the next 5 ½ years Arctic Trucks specializes in re-engineering and conversion of four-wheel drive vehicles for extreme conditions VivoPower estimates the value of the Proposed Agreement to be US$58m The Proposed Agreement would mark the Company’s third major distribution deal across three continentsLONDON, June 02, 2021 (GLOBE NEWSWIRE) — VivoPower International PLC (NASDAQ: VVPR, the “Company”) is pleased to announce that the Company and its wholly-owned subsidiary, Tembo e-LV B.V. (“Tembo”), have entered into a non-binding Heads of Terms with leading ruggedized vehicle converter Arctic Trucks Limited (“Arctic Trucks”) for Arctic Trucks to convert and distribute Tembo electric...

Continue reading

ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) — ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional bioproduct candidates originally derived from proprietary algal cultures, today announced that President & Chief Executive Officer Andrew Dahl will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021. Mr. Dahl will deliver his corporate presentation on June 9 at 6:00pm ET, Track 3. Investors can register to watch the presentation here. Investors interested in scheduling a meeting with management should contact assistant@ldmicro.com. About ZIVO Bioscience, Inc.ZIVO Bioscience, Inc. (NASDAQ: ZIVO) is a Michigan-based biotech/agtech company dedicated...

Continue reading

CN Receives More Than 400 Additional Letters of Support Since Signing Agreement to Combine With Kansas City Southern

Stakeholder support for pro-competitive combination between CN and KCS continues to grow MONTREAL and KANSAS CITY, Mo., June 02, 2021 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) and Kansas City Southern (“KCS”) (NYSE: KSU) today announced that the overwhelming stakeholder support for their proposed pro-competitive combination continues to grow with more than 400 additional letters of support filed with the Surface Transportation Board (“STB”) since the two companies agreed to combine, taking the total to over 1,400, including a letter of support from Governor John Bel Edwards of Louisiana. The proposed combination between CN and KCS will create a transportation network across North America, enhancing competition, spurring economic growth and delivering benefits to the local communities in which both railroads operate. The combination,...

Continue reading

Metso Outotec to Commence Development Review – Kubi Gold Project Ghana

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — Asante Gold Corporation (CSE:ASE/ FRANKFURT:1A9/U.S.OTC:ASGOF) (“Asante” or the “Company”) is pleased to announce that Metso Outotec has been engaged as a Principle Project Development Partner to complete a preliminary capital and operating cost estimate on treatment options for processing of free-milling gold from our Kubi Gold Project in Ghana. Metso Outotec is a frontrunner in sustainable technologies, end-to-end solutions and services for the minerals processing, metals refining and aggregates industries globally. Their focus is on improving energy and water efficiency, productivity, and reducing environmental risk. Headquartered in Helsinki, Finland, Metso Outotec...

Continue reading

Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB-100 for Treatment of Small Cell Lung Cancer

Extensive preclinical data shows LB-100 increases the effectiveness of chemotherapy in animal models Due to the aggressive progression of small cell lung cancer, it is possible that therapeutic benefit in patients may be seen in this early-stage clinical trialEAST SETAUKET, NY, June 02, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing pharmacologically active drugs for use in cancer treatment, today announced the enrollment of the first patient in a Phase 1b clinical trial with City of Hope, a world-renowned independent cancer research and treatment center. The trial will assess the combination of Lixte’s first-in-class protein phosphatase 2A (PP2A) inhibitor LB-100 with a standard regimen for previously untreated, extensive stage-disease small cell...

Continue reading

AB Science will host a live webcast on June 3, 2021 following the voluntary hold in the clinical studies of masitinib

PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON THURSDAY JUNE 3, 2021 FOLLOWING THE VOLUNTARY HOLD IN THE CLINICAL STUDIES OF MASITINIB Paris, June 2, 2021 3.30pm AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on June 3, 2021 to provide details on the decision to suspend voluntarily the clinical studies with masitinib. The following attendees will participate to the webcast:Alain Moussy, co-founder and CEO of AB Science Christian Fassotte, MD, Chief Medical Officer of AB Science Peter De Veene, MD, Head of Pharmacovigilance and Global Safety of AB Science Olivier Hermine, MD, PhD, Chief of adults Hematology staff at Hospital Necker in Paris, France, president of AB Science scientific committee and member of the French Académie des SciencesThe webcast call will be held on Thursday June 3, 2021 from 6.30pm...

Continue reading

HUMBL Announces Strategic Collaboration with Athletes First

Athletes FirstStrategic Collaboration with Athletes FirstSan Diego, California, June 02, 2021 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC Markets: HMBL) announced today it has retained Athletes First as a strategic consultant to focus on the development of new business verticals in such areas as non-fungible tokens (NFTs), digital media and ticketing. Athletes First is a leading sports agency with a multi-decade history of representing top NFL players, coaches, executives and broadcasters. The Athletes First client roster includes hundreds of NFL players such as Aaron Rodgers, Tua Tagovailoa, Justin Herbert, Jalen Ramsey, Sterling Shepard, Derwin James, Chase Claypool, and Justin Fields, along with retired stars such as Hall of Famers Steve Young and John Lynch, and over 100 NFL and NCAA coaches. Athletes First will support...

Continue reading

AVCtechnologies Named to the CRN® 2021 Solution Provider 500 List

Computex, an AVCtechnologies brand, listed as a top revenue leading IT channel partner in North America for the ninth consecutive year ATLANTA, June 02, 2021 (GLOBE NEWSWIRE) — American Virtual Cloud Technologies Inc. (NASDAQ: AVCT) (AVCtechnologies), the leading cloud communications and IT service provider, announced today that AVCtechnologies’ brand, Computex Technology Solutions (“Computex”), has been named to the CRN®, a brand of The Channel Company, top 500 solution providers list for the ninth consecutive year. Released annually, the list ranks the top integrators, service providers and IT consultants in North America by services revenue. The organizations in this year’s Solution Provider 500 list represent a remarkable combined annual revenue of more than $403 billion, underscoring the immense impact and influence they have...

Continue reading

Search Minerals Announces Our 2021 Rare Earth Element Drilling Program Has Started in Labrador

VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — Search Minerals Inc. (TSXV: SMY) (“Search” or the “Company”) is pleased to announce its 2021 drilling and exploration program for Critical Rare Earth Elements (CREE), Zirconium (Zr) and Hafnium (Hf) in the Port Hope Simpson – St. Lewis CREE District in SE Labrador, has begun. Ms. Suzanne Butler, our senior geologist, has opened up our recently purchased Fox Harbour House, and welcomed back our employees for a very busy 2021 drilling and exploration season. Our drilling contractor, Springdale Forest Resources Inc., has arrived and are eager to initiate our 7000m drill program on our wholly owned Deep Fox project and Dr Randy Miller will be arriving shortly as well. We are funded with $ 2,520,000 from our successful flow through funding initiative completed in April 2021....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.